Literature DB >> 20933172

Catatonia is hidden in plain sight among different pediatric disorders: a review article.

Dirk M Dhossche1, Lee E Wachtel.   

Abstract

Over the past two decades, catatonia has been better demarcated in adult psychiatry as a unique syndrome that consists of specific motor signs with a characteristic response to benzodiazepines and electroconvulsive therapy. Pediatric catatonia is considered rare, but may be underdiagnosed, and hence undertreated. Discussed here are the current diagnostic criteria of catatonia in individual cases of children and adolescents diagnosed with childhood disintegrative disorder, Kleine-Levin syndrome, Prader-Willi syndrome, tic disorder, and autoimmune encephalitis, and the effects of benzodiazepines and electroconvulsive therapy. In these cases, catatonia resolved safely once it was recognized and treated properly. Children and adolescents presenting with these disorders should be systematically assessed for catatonia; when the presence of catatonia is confirmed, the use of benzodiazepines and electroconvulsive therapy should be considered. The occurrence of catatonia in such a wide range of child and adolescent disorders supports the view that pediatric catatonia is not so rare, that there are shared elements in the etiology, psychopathology, and pathophysiology of these disorders, and that catatonia is best classified as a unique neurobiologic syndrome.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20933172     DOI: 10.1016/j.pediatrneurol.2010.07.001

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  21 in total

1.  Treatment use in a prospective naturalistic cohort of children and adolescents with catatonia.

Authors:  Marie Raffin; Laetitia Zugaj-Bensaou; Nicolas Bodeau; Vanessa Milhiet; Claudine Laurent; David Cohen; Angèle Consoli
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-08-27       Impact factor: 4.785

2.  A Case of Recurrent Hypersomnia With Autonomic Dysfunction.

Authors:  Mandana Mahmoudi; Daniel Friedman; Martina Vendrame; Sanjeev V Kothare
Journal:  J Clin Sleep Med       Date:  2017-07-15       Impact factor: 4.062

3.  Anti-NMDA receptor encephalitis versus pediatric catatonia.

Authors:  Dirk Dhossche; Max Fink; Edward Shorter; Lee E Wachtel
Journal:  Am J Psychiatry       Date:  2011-07       Impact factor: 18.112

4.  Catatonia and refractory agitation in an updated flow chart for the evaluation of emotional-behavioral disturbances in severely ill children.

Authors:  Maite M Esseveld; Piet L M N Leroy; Carsten Leue; Jacqueline Strik; Marijntje Tijssen; Emma H C W van de Riet; Jan N M Schieveld
Journal:  Intensive Care Med       Date:  2012-11-30       Impact factor: 17.440

Review 5.  Autoimmune encephalitis in children.

Authors:  Thaís Armangue; Mar Petit-Pedrol; Josep Dalmau
Journal:  J Child Neurol       Date:  2012-08-29       Impact factor: 1.987

6.  Catatonia in a 6-year-old Patient Following Disseminated Group A Streptococcus Infection.

Authors:  Philip B Cawkwell; Ivan Daniel Mayor; Richard J Shaw
Journal:  Innov Clin Neurosci       Date:  2021-01-01

7.  The Interoception Sensory Questionnaire (ISQ): A Scale to Measure Interoceptive Challenges in Adults.

Authors:  L Fiene; M J Ireland; C Brownlow
Journal:  J Autism Dev Disord       Date:  2018-10

8.  Possible Commonalities of Clinical Manifestations Between Dystonia and Catatonia.

Authors:  Kanako Ishizuka; Masako Tachibana; Toshiya Inada
Journal:  Front Psychiatry       Date:  2022-04-29       Impact factor: 4.157

9.  Catatonia in Ugandan children with nodding syndrome and effects of treatment with lorazepam: a pilot study.

Authors:  Angelina Kakooza-Mwesige; Dirk M Dhossche; Richard Idro; Dickens Akena; Joyce Nalugya; Benard T Opar
Journal:  BMC Res Notes       Date:  2015-12-28

10.  Catatonia in Older Adult Individuals with Intellectual Disabilities.

Authors:  Megan White; Edward Maxwell; Warren E Milteer; Jose de Leon
Journal:  Case Rep Psychiatry       Date:  2015-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.